Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	155
Overall Study	STARTED	Dapagliflozin 10 mg	145
Overall Study	STARTED	Placebo	148
Overall Study	Received Treatment	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	152
Overall Study	Received Treatment	Dapagliflozin 10 mg	145
Overall Study	Received Treatment	Placebo	148
Overall Study	Full Analysis Set	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	152
Overall Study	Full Analysis Set	Dapagliflozin 10 mg	144
Overall Study	Full Analysis Set	Placebo	148
Overall Study	Safety Analysis Set	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	152
Overall Study	Safety Analysis Set	Dapagliflozin 10 mg	145
Overall Study	Safety Analysis Set	Placebo	148
Overall Study	COMPLETED	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	150
Overall Study	COMPLETED	Dapagliflozin 10 mg	137
Overall Study	COMPLETED	Placebo	143
Overall Study	NOT COMPLETED	Dapagliflozin 10 mg + Saxagliptin 2.5 mg	5
Overall Study	NOT COMPLETED	Dapagliflozin 10 mg	8
Overall Study	NOT COMPLETED	Placebo	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02547935/flow